REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 187 filers reported holding REVANCE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $20,260,000 | 52.86% |
| Essex Woodlands Management, Inc. | 3,342,047 | $43,447,000 | 27.06% |
| Sio Capital Management, LLC | 305,664 | $3,974,000 | 1.28% |
| Fosun International Ltd | 472,532 | $6,143,000 | 0.68% |
| ArrowMark Colorado Holdings LLC | 4,831,653 | $62,811,000 | 0.63% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,078,697 | $14,023,000 | 0.50% |
| Rhenman & Partners Asset Management AB | 173,917 | $2,261,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 26,365 | $343,000 | 0.14% |
| FIRST MIDWEST BANK TRUST DIVISION | 67,141 | $873,000 | 0.13% |
| Rock Creek Group, LP | 18,500 | $241,000 | 0.12% |